Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.41 USD | +1.35% | -2.67% | -9.89% |
Apr. 18 | Citigroup Adjusts CRISPR Therapeutics' Price Target to $89 From $88, Keeps Buy Rating | MT |
Apr. 17 | Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 121M | Sales 2025 * | 404M | Capitalization | 4.79B |
---|---|---|---|---|---|
Net income 2024 * | -454M | Net income 2025 * | -381M | EV / Sales 2024 * | 26.6 x |
Net cash position 2024 * | 1.55B | Net cash position 2025 * | 1.39B | EV / Sales 2025 * | 8.4 x |
P/E ratio 2024 * |
-10.3
x | P/E ratio 2025 * |
-13.3
x | Employees | 407 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.94% |
Latest transcript on CRISPR Therapeutics AG
1 day | +1.35% | ||
1 week | -2.67% | ||
Current month | -17.24% | ||
1 month | -21.23% | ||
3 months | -14.78% | ||
6 months | +40.67% | ||
Current year | -9.89% |
Managers | Title | Age | Since |
---|---|---|---|
Samarth Kulkarni
CEO | Chief Executive Officer | 45 | 15-07-31 |
Raju Prasad
DFI | Director of Finance/CFO | 40 | 23-03-13 |
Stephen Kennedy
CTO | Chief Tech/Sci/R&D Officer | 67 | 19-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Doug Treco Treco
BRD | Director/Board Member | 66 | 20-06-10 |
Simeon George
BRD | Director/Board Member | 46 | 15-04-28 |
Ali Behbahani
BRD | Director/Board Member | 47 | 15-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
10.82% | 215 M€ | +11.92% | - | |
8.55% | 2 M€ | -25.75% | ||
4.84% | 1 M€ | 0.00% | - | |
4.53% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 56.41 | +1.35% | 1,190,566 |
24-04-22 | 55.66 | +1.11% | 1,044,335 |
24-04-19 | 55.05 | -1.98% | 1,766,181 |
24-04-18 | 56.16 | +1.08% | 1,745,393 |
24-04-17 | 55.56 | -4.14% | 1,399,569 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.89% | 4.79B | |
+3.13% | 43.43B | |
+47.30% | 41.69B | |
+8.49% | 41.31B | |
-10.82% | 27.14B | |
+8.26% | 25.28B | |
-23.69% | 18.47B | |
+1.58% | 12.33B | |
+32.83% | 12.59B | |
+6.63% | 11.03B |
- Stock Market
- Equities
- CRSP Stock